| Name | TPN171 |
|---|
| Description | TPN171 is a potent, selective and oral bioavailable inhibitor of phosphodiesterase type 5 (PDE5) with an IC50 of 0.62 nM, being developed for the treatment of pulmonary arterial hypertension (PAH)[1]. |
|---|---|
| Related Catalog | |
| Target |
PDE5:0.62 nM (IC50) |
| References |
| Molecular Formula | C24H35N5O3 |
|---|---|
| Molecular Weight | 441.57 |